TV.QIAGENBIOINFORMATICS.COM
COSMIC
Standardize tumor classification and variant annotation for reproducible...
Accurate interpretation of cancer genomics depends on standardized disease...
QIAGEN CLC Genomics
Population Genetics in an Era of Genomic Health
Advances in genomic medicine hold enormous promise, but that promise cannot be fully...
QIAGEN CLC Genomics
Single-cell RNA-seq, cell hashing and spatial transcriptomics
In this training, you will learn how to analyze and interpret your own single cell...
QIAGEN CLC Genomics
NGS for GMP compliance: New guidelines, new tools
The updated ICH Q5A(R2) guidelines recommend next-generation sequencing (NGS) as the...
QIAGEN IPA
From ‘Omics to Insights Part 2: Interpret Your IPA Core Analysis Results
This is the second part of a series on how you can easily turn your ‘omics data into...
QIAGEN IPA
IPA Interpret: A hands-on workshop
Now, you can access and share the interpretative power of QIAGEN Ingenuity Pathway...
QIAGEN IPA
IPA deeper dive miRNA investigation using QIAGEN Ingenuity Pathway Analysis
In this 90-minute training session, you will learn how to identify target mRNAs for...
QIAGEN IPA
From ‘Omics to Insights Part 1: IPA Dataset Prep and Core Analysis Setup
This is the first part of a series on how you can easily turn your ‘omics data into...
HGMD
Hybrid Variant Interpretation: Combining AI + Expert Curation to Streamline...
As hereditary NGS testing grows more complex, clinical labs must interpret variants...
QCI Interpret for Oncology
Is it oncogenic? Comparing guidelines and QCI Interpret CDS for cancer...
Accurate clinical interpretation of somatic cancer variants is critical for diagnosis...
QIAGEN OmicSoft and Biomedical Knowledge Base
OmicSoft Explorer Hands-on Workshop: Easily search and interpret deeply...
This hands-on workshop will cover a highly requested use case using OmicSoft Explorer...
QIAGEN CLC Genomics
Long reads analysis using QIAGEN CLC Genomics Workbench
This webinar will introduce you to the Long Read Support plugin for Oxford Nanopore and...